Jean–Frédéric Colombel

13.4k total citations · 6 hit papers
75 papers, 8.9k citations indexed

About

Jean–Frédéric Colombel is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Jean–Frédéric Colombel has authored 75 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Genetics, 50 papers in Epidemiology and 28 papers in Surgery. Recurrent topics in Jean–Frédéric Colombel's work include Inflammatory Bowel Disease (68 papers), Microscopic Colitis (48 papers) and Eosinophilic Esophagitis (12 papers). Jean–Frédéric Colombel is often cited by papers focused on Inflammatory Bowel Disease (68 papers), Microscopic Colitis (48 papers) and Eosinophilic Esophagitis (12 papers). Jean–Frédéric Colombel collaborates with scholars based in France, United States and Canada. Jean–Frédéric Colombel's co-authors include William J. Sandborn, Laurent Peyrin‐Biroulet, Stefan Schreiber, Simon Travis, Bruce E. Sands, Paul Rutgeerts, Remo Panaccione, Paul F. Pollack, Robert Enns and Ju Li and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Gastroenterology.

In The Last Decade

Jean–Frédéric Colombel

67 papers receiving 8.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

2006 1.7k citations Jean–Frédéric Colombel, William J. Sandborn et al. Gastroenterology profile →
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

2012 1.2k citations Jean–Frédéric Colombel, Matthieu Allez et al. Journal of Crohn s and Colitis profile →
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

2012 638 citations Jean–Frédéric Colombel, Séverine Vermeire et al. Journal of Crohn s and Colitis profile →
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

2006 607 citations Jean–Frédéric Colombel et al. profile →
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

2019 461 citations Bruce E. Sands, Laurent Peyrin‐Biroulet et al. New England Journal of Medicine profile →
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

2011 441 citations Simon Travis, Dan Schnell et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean–Frédéric Colombel France	35	7.0k	5.5k	2.7k	1.6k	951	75	8.9k
A. Hillary Steinhart Canada	45	6.5k 0.9×	5.1k 0.9×	2.3k 0.9×	1.5k 0.9×	724 0.8×	146	8.5k
Gerassimos J. Mantzaris Greece	41	8.0k 1.1×	6.3k 1.2×	3.4k 1.3×	1.9k 1.2×	1.1k 1.1×	145	10.5k
Fernando Magro Portugal	41	5.5k 0.8×	4.2k 0.8×	2.4k 0.9×	1.5k 0.9×	714 0.8×	307	8.6k
Asher Kornbluth United States	36	7.6k 1.1×	6.1k 1.1×	3.4k 1.2×	1.4k 0.9×	1.3k 1.4×	97	10.1k
Maja Noman Belgium	37	7.1k 1.0×	5.6k 1.0×	2.2k 0.8×	2.9k 1.8×	737 0.8×	100	9.8k
Walter Reinisch Austria	41	5.6k 0.8×	4.1k 0.8×	2.0k 0.7×	2.0k 1.2×	654 0.7×	223	8.1k
Gary Wild Canada	33	5.3k 0.8×	3.8k 0.7×	2.1k 0.8×	1.7k 1.1×	635 0.7×	144	7.7k
Adam S. Cheifetz United States	49	4.9k 0.7×	3.6k 0.7×	1.9k 0.7×	2.3k 1.4×	889 0.9×	213	7.7k
Shomron Ben‐Horin Israel	54	6.6k 1.0×	4.8k 0.9×	2.8k 1.0×	3.2k 2.0×	1.5k 1.6×	310	10.5k
Jørgen Jahnsen Norway	40	5.0k 0.7×	4.7k 0.9×	2.3k 0.8×	1.4k 0.9×	1.3k 1.3×	149	7.6k

Countries citing papers authored by Jean–Frédéric Colombel

Since Specialization

Citations

This map shows the geographic impact of Jean–Frédéric Colombel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean–Frédéric Colombel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean–Frédéric Colombel more than expected).

Fields of papers citing papers by Jean–Frédéric Colombel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean–Frédéric Colombel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean–Frédéric Colombel. The network helps show where Jean–Frédéric Colombel may publish in the future.

Co-authorship network of co-authors of Jean–Frédéric Colombel

This figure shows the co-authorship network connecting the top 25 collaborators of Jean–Frédéric Colombel. A scholar is included among the top collaborators of Jean–Frédéric Colombel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean–Frédéric Colombel. Jean–Frédéric Colombel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vermeire, Séverine, Jean–Frédéric Colombel, Silvio Danese, et al.. (2025). Benefit–risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn’s disease. Journal of Crohn s and Colitis. 20(1).

Kayal, Maia, Vipul Jairath, Anila Qasim, et al.. (2025). Scoring indices for assessing endoscopic disease activity in acute severe ulcerative colitis: a systematic review. Journal of Crohn s and Colitis. 19(9).

Alayo, Quazim A., Andrés Yarur, Deborah A. Thomas, et al.. (2025). Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. 32(1). 39–52.

Panaccione, Remo, Édouard Louis, Jean–Frédéric Colombel, et al.. (2025). Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies. Journal of Crohn s and Colitis. 19(1). 5 indexed citations

Bachour, Salam, Manasi Agrawal, Henrik Jacobsen, et al.. (2025). Cross-Sectional Imaging Features Associated With Disease Progression in Crohn’s Disease. Inflammatory Bowel Diseases. 32(2). 228–236.

Nirenberg, Sharon, Jean–Frédéric Colombel, Adam S. Faye, et al.. (2024). Intravenous Steroids Do Not Improve Short-Term Outcomes of Patients With Crohn’s Disease Presenting With an Acute Small Bowel Obstruction. Crohn s & Colitis 360. 7(1). otae064–otae064.

Colombel, Jean–Frédéric, Ana P. Lacerda, Peter M. Irving, et al.. (2024). Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn’s Disease: A Post Hoc Analysis of 3 Phase 3 Trials. Clinical Gastroenterology and Hepatology. 23(6). 1019–1029. 11 indexed citations

Cleveland, Noa Krugliak, Brian Bressler, Corey A. Siegel, et al.. (2022). A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities. Gastroenterology. 163(6). 1505–1509. 6 indexed citations

Chapman, Thomas, C Frias Gomes, Édouard Louis, Jean–Frédéric Colombel, & Jack Satsangi. (2020). Review article: withdrawal of 5‐aminosalicylates in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 52(1). 73–84. 33 indexed citations

10.

Sands, Bruce E., Laurent Peyrin‐Biroulet, Edward V. Loftus, et al.. (2019). Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. New England Journal of Medicine. 381(13). 1215–1226. 461 indexed citations breakdown →

11.

Jones, Jennifer, Gilaad G. Kaplan, Laurent Peyrin‐Biroulet, et al.. (2015). Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials. Clinical Gastroenterology and Hepatology. 13(13). 2233–2240.e2. 90 indexed citations

12.

Danese, Silvio, Gionata Fiorino, Jean-Yves Mary, et al.. (2015). Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn’s Disease: An IOIBD Initiative. Journal of Crohn s and Colitis. 9(8). 601–606. 79 indexed citations

13.

Billioud, Vincent, Alexander C. Ford, Émilie Del Tedesco, et al.. (2013). Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis. Journal of Crohn s and Colitis. 7(11). 853–867. 143 indexed citations

14.

Charpentier, Cloé, Julia Salleron, Guillaume Savoye, et al.. (2013). Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 63(3). 423–432. 252 indexed citations

15.

Fuméry, Mathurin, Xiaocang Cao, Luc Dauchet, et al.. (2013). Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: A meta-analysis of observational studies. Journal of Crohn s and Colitis. 8(6). 469–479. 146 indexed citations

16.

Hébuterne, Xavier, Marc Lémann, Yoram Bouhnik, et al.. (2012). Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol. Gut. 62(2). 201–208. 129 indexed citations

17.

Boualit, Médina, Julia Salleron, Dominique Turck, et al.. (2012). Long-term Outcome After First Intestinal Resection in Pediatric-onset Crohnʼs Disease. Inflammatory Bowel Diseases. 19(1). 7–14. 34 indexed citations

18.

Colombel, Jean–Frédéric, Édouard Louis, Laurent Peyrin‐Biroulet, William J. Sandborn, & Remo Panaccione. (2012). Deep Remission: A New Concept?. Digestive Diseases. 30(Suppl. 3). 107–111. 34 indexed citations

19.

Jung, Camille, Jean–Frédéric Colombel, Marc Lémann, et al.. (2012). Genotype/Phenotype Analyses for 53 Crohn’s Disease Associated Genetic Polymorphisms. PLoS ONE. 7(12). e52223–e52223. 42 indexed citations

20.

Travis, Simon, Dan Schnell, Piotr Krzeski, et al.. (2011). Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut. 61(4). 535–542. 441 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact